STUDIES ON ANTIBLASTIC IMMUNITY

Area of Science:

• Microbiology
• Immunology

Background:

• Antipneumococcus serum has shown inhibitory effects on pneumococcus metabolic activities.
• The precise mechanism behind this inhibition, whether enzymatic or otherwise, requires elucidation.

Purpose of the Study:

• To investigate the mechanism by which antipneumococcus serum inhibits pneumococcus metabolic activities.
• To determine if the inhibitory effect is due to a specific antienzymotic property or other factors.

Main Methods:

• Testing antipneumococcus serum with varying agglutinin content against pneumococcus.
• Observing the correlation between serum agglutinating power and inhibitory action.
• Evaluating the effect of antistaphylococcus serum on Staphylococcus pyogenes aureus metabolic activities.

Main Results:

• Antipneumococcus serum's inhibitory effect is directly proportional to its agglutinating power.
• Serum lacking agglutinins showed no inhibitory properties.
• The observed inhibition is attributed to agglutination, hindering bacterial interaction with the medium, not a specific antienzymotic effect.
• Antistaphylococcus serum inhibited gelatin liquefaction and pigment formation but not essential growth activities of Staphylococcus pyogenes aureus.

Conclusions:

• The inhibition of pneumococcus metabolic activity by antipneumococcus serum is primarily a consequence of agglutination.
• The mechanism is not due to a specific antienzymotic property of the serum.
• Further research is needed to fully understand the inhibitory actions of antistaphylococcus serum.